310 related articles for article (PubMed ID: 20507579)
1. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
2. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
3. Elevated Neutrophil-to-Lymphocyte Ratio in Metabolic Syndrome Is Associated with Increased Risk of Colorectal Adenoma.
Kim JH; Cho KI; Kim YA; Park SJ
Metab Syndr Relat Disord; 2017 Oct; 15(8):393-399. PubMed ID: 28910195
[TBL] [Abstract][Full Text] [Related]
4. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps.
Fliss-Isakov N; Zelber-Sagi S; Webb M; Halpern Z; Shibolet O; Kariv R
Obesity (Silver Spring); 2017 Nov; 25 Suppl 2():S72-S80. PubMed ID: 29086511
[TBL] [Abstract][Full Text] [Related]
5. Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwanese population receiving screening colonoscopy.
Hu NC; Chen JD; Lin YM; Chang JY; Chen YH
J Formos Med Assoc; 2011 Feb; 110(2):100-8. PubMed ID: 21377064
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).
Ku MS; Chiu SY; Chien KL; Lee YC; Chen SL; Chen CD
Medicine (Baltimore); 2021 Jun; 100(22):e26121. PubMed ID: 34087861
[TBL] [Abstract][Full Text] [Related]
7. Association of colorectal adenoma with components of metabolic syndrome.
Kim BC; Shin A; Hong CW; Sohn DK; Han KS; Ryu KH; Park BJ; Nam JH; Park JW; Chang HJ; Choi HS; Kim J; Oh JH
Cancer Causes Control; 2012 May; 23(5):727-35. PubMed ID: 22450737
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
Wu H; Zhang J; Zhou B
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
[TBL] [Abstract][Full Text] [Related]
9. Obesity-related parameters and colorectal adenoma development.
Kim TJ; Kim JE; Choi YH; Hong SN; Kim YH; Chang DK; Rhee PL; Kim MJ; Jung SH; Son HJ
J Gastroenterol; 2017 Dec; 52(12):1221-1229. PubMed ID: 28197803
[TBL] [Abstract][Full Text] [Related]
10. [Distribution characteristics and risk factors of colorectal adenomas].
Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
[TBL] [Abstract][Full Text] [Related]
11. Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study.
Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
PLoS One; 2018; 13(8):e0202757. PubMed ID: 30142166
[TBL] [Abstract][Full Text] [Related]
12. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.
Aleksandrova K; Boeing H; Jenab M; Bas Bueno-de-Mesquita H; Jansen E; van Duijnhoven FJ; Fedirko V; Rinaldi S; Romieu I; Riboli E; Romaguera D; Overvad K; Østergaard JN; Olsen A; Tjønneland A; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Masala G; Agnoli C; Panico S; Tumino R; Vineis P; Kaaks R; Lukanova A; Trichopoulou A; Naska A; Bamia C; Peeters PH; Rodríguez L; Buckland G; Sánchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Hallmans G; Palmqvist R; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Pischon T
Cancer Prev Res (Phila); 2011 Nov; 4(11):1873-83. PubMed ID: 21697276
[TBL] [Abstract][Full Text] [Related]
14. [Incidence of metabolic syndrome and associated lifestyle factors in a worksite male population].
Otsuka T; Kawada T; Yanai M; Kitagawa Y; Kan H
Sangyo Eiseigaku Zasshi; 2011; 53(3):78-86. PubMed ID: 21372516
[TBL] [Abstract][Full Text] [Related]
15. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract][Full Text] [Related]
16. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study.
Hsieh YH; Wu MF; Yang PY; Liao WC; Hsieh YH; Chang YJ; Lin IC
BMC Gastroenterol; 2019 Feb; 19(1):33. PubMed ID: 30782138
[TBL] [Abstract][Full Text] [Related]
17. Association of body fat distribution and metabolic syndrome with the occurrence of colorectal adenoma: A case-control study.
Liu ZH; Zhang GX; Zhang H; Jiang L; Deng Y; Chan FSY; Fan JKM
J Dig Dis; 2021 Apr; 22(4):222-229. PubMed ID: 33656773
[TBL] [Abstract][Full Text] [Related]
18. [Association of colorectal adenoma and metabolic syndrome and relevant parameters].
Liu Z; Hu X; Cui S; Gu J; Joe King Man F; Fion Siu Yin C; Peng J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):675-9. PubMed ID: 27353103
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
Liljegren A; Barker G; Elliott F; Bertario L; Bisgaard ML; Eccles D; Evans G; Macrae F; Maher E; Lindblom A; Rotstein S; Nilsson B; Mecklin JP; Möslein G; Jass J; Fodde R; Mathers J; Burn J; Bishop DT
J Clin Oncol; 2008 Jul; 26(20):3434-9. PubMed ID: 18612159
[TBL] [Abstract][Full Text] [Related]
20. Association between metabolic syndrome and early-stage colorectal cancer.
Zhang C; Zhang L; Tian Y; Guan B; Li S
BMC Cancer; 2023 Oct; 23(1):1020. PubMed ID: 37872512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
